Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
innovative employers in the region. With more than 6000 employees from 100 different countries, we are helping to build tomorrow's world every day. Through top scientific research, we push back boundaries and
-
neuroscience research on a cell-to-organism wide scale. Via the IMARK Valorisation consortium , aimed at expediting biomarker discovery and development by resolving molecular and structural patterns in space and
-
cell-to-organism wide scale. Via the IMARK Valorisation consortium , aimed at expediting biomarker discovery and development by resolving molecular and structural patterns in space and time, we are also
-
the mechanisms through which SAA3 activates immune cells (particularly glia) in the enteric and the central nervous system. This way we intend to further our understanding of pathogenic gut-brain communication and
-
of proteomics and auditory neuroscience. This 3-year scholarship is focused on the identification of proteins important in the functional cochlea generally, and the hair cells in the organ of Corti more
-
. We are one of the largest, most international and most innovative employers in the region. With more than 6000 employees from 100 different countries, we are helping to build tomorrow's world every day
-
innovative employers in the region. With more than 6000 employees from 100 different countries, we are helping to build tomorrow's world every day. Through top scientific research, we push back boundaries and
-
9 Mar 2024 Job Information Organisation/Company University of Antwerp Research Field Chemistry » Biochemistry Medical sciences » Other Technology » Biotechnology Researcher Profile First Stage
-
of the largest, most international and most innovative employers in the region. With more than 6000 employees from 100 different countries, we are helping to build tomorrow's world every day. Through top
-
. The preliminary data generated in-house as well as the available public data suggest mechanisms involving genetic, epigenetic and chromatin organisation factors governing the cell-type specific response to ARS